The Cell and Gene Therapy Catapult is placing the UK at the centre of a global cell and gene therapy industry. It is committed to the advancement of cell and gene therapies and has a vision for a thriving industry delivering life-changing advanced therapies to health providers and patients worldwide.
This industry requires a highly specialised workforce which the Cell and Gene Therapy Catapult has predicted will grow by 117% between 2021 to 2026. The types of skills required include cell and gene therapy manufacturing, supply chains, logistics, and quality and process development.
The Cell and Gene Therapy Catapult has taken the lead on surveying the industry to understand requirements and helped create, nurture and deliver the unique Advanced Therapies Apprenticeship Community (ATAC) focused on the development of new talent, upskilling in the sector and transferability from other sectors. Nearly 300 people have enrolled on apprenticeships organised and supported by ATAC and the programme has a high retention rate at 85%.
In partnership with industry, Cell and Gene Therapy Catapult also developed an Online Training Platform and identified a network of training centres focused on the manufacturing skills gaps for cell and gene therapies. There are over 2,300 active users of the Online Training Platform, which currently contains over 750 learning modules.
The Cell and Gene Therapy Catapult’s Advanced Therapies Skills Training Network has developed a Career Converter, a unique, cutting-edge tool that helps people measure their transferable skills against in-demand roles within the advanced therapies and vaccine manufacturing sectors. In 2022, the Cell and Gene Therapy Catapult opened its dedicated Skills and Training Laboratories in Sycamore House, Stevenage. These laboratories provide access to state-of-the-art equipment and training facilities and aim to help provide a supply of trained talent for the advanced therapies industry. For example, the labs are home to virtual reality (VR) platforms developed in collaboration with UK companies, which allows for staff to be trained in VR simulations before moving into the real lab.